CLINICAL-IQ™
Accelerate Timelines, Enhance Engagement: DCT Solutions That Deliver
Traditional clinical trials can be time-consuming and inefficient. Our software solutions enable biopharma companies to conduct decentralized clinical trials (DCT) that accelerate trial timelines, enhance participant engagement, and improve overall trial efficiency.
Achieve Patient centric Clinical Trial management with DCT supported solution to maximize patient participation
End-to-End Trial Management
-
Design, manage, and analyze every aspect of a trial or study with the robust suite of tools in the Clinical-IQ Management Portal
-
Version control and optional approval flows for all components of trial creation and management provide clear visibility and traceability to assist in accuracy and compliance
-
Define the schedule of your trial to automatically associate the appropriate activities to participants at each trial milestone
-
For trials with open recruitment, the Clinical-IQ Participant Portal provides public landing pages for your trial for use in campaigns with full prescreening and registration capabilities
-
To assist in monitoring trial interest and campaign success, all public recruitment features are equipped to support industry-standard UTM parameters for user tracking analytics
Trial Management: Surveys
-
Using the Survey Editor, create dynamic surveys for each stage in the trial lifecycle
-
Select from a variety of question types, customize lists in multiple-choice lists and dropdowns, and organize questions into pages to optimize the participant experience
-
Configure questions to be required, optional, or to show conditionally based on previous answers or participant demographics
-
Define qualification criteria for applicable surveys using specific responses or by establishing score-based thresholds for groups of questions
-
Associate and order surveys within scheduled trial intervals to establish the appropriate cadence for electronic patient-reported outcomes (ePRO)
Trial Management: Consent
-
Using the Consent Editor, enter the content of a trial’s Informed Consent document or copy from an existing document
-
Preview the final PDF format of the Informed Consent during editing to confirm clear readability of the content and layout
-
When associated with a trial, the Informed Consent will be delivered to the participant through the Clinical-IQ Participant Portal for electronic signature
-
After participant signature, the document is returned to the trial team through the Clinical-IQ Management Portal for counter-signature and final document execution
-
Fully-executed Informed Consent documents are stored securely and only accessible to the signing participant and privileged trial team users
-
All electronic signatures and consent document controls are compliant with the 21 CFR Part 11 FDA guidelines
Participant Experience
-
Using the Clinical-IQ Participant Portal, the trial participant has a streamlined, mobile-optimized platform to easily complete consent and ePRO activities
-
Automated reminders are sent through email or text (based on participant preference) when new activities are assigned or existing activities are nearing expiration
-
Participants can also use their portal to edit their profile information, view their activity history, or download their executed Informed Consent document as required by 21 CFR Part 11
Reporting & Analytics
-
Using the Consent Editor, enter the content of a trial’s Informed Consent document or copy from an existing document
-
Preview the final PDF format of the Informed Consent during editing to confirm clear readability of the content and layout
-
When associated with a trial, the Informed Consent will be delivered to the participant through the Clinical-IQ Participant Portal for electronic signature
-
After participant signature, the document is returned to the trial team through the Clinical-IQ Management Portal for counter-signature and final document execution
-
Fully-executed Informed Consent documents are stored securely and only accessible to the signing participant and privileged trial team users
-
All electronic signatures and consent document controls are compliant with the 21 CFR Part 11 FDA guidelines